RxDoctor Payments Data

Jessica Heintz, MD

Hospice and Palliative Medicine · Fairfax, VANPI 1477546695

Payments from drug & device makers

What this record shows

This record is dominated by travel and lodging: $1,475 of the $1,915 with a category attached, or 77.0%. AbbVie accounts for 78.7% of it on its own, with 13 other manufacturers making up the rest. Reporting peaked in 2023 at $1,508 and has fallen 93.5% since, to $98 in 2025. Among hospice and palliative medicine clinicians in VA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$1,915in general payments, 2019–2025

Across 18 payments — averaging $106.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Novartis$67
  • Johnson & Johnson$50
  • AstraZeneca$34
  • Regeneron Healthcare Solutions, Inc.$34
  • Merck$33
  • plus $190 from 8 others

What the payments were for

  • Travel & lodging$1,47577%
  • Food & beverage$44023%

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,915 in reported general payments places this provider in the 90th percentile of 45 hospice and palliative medicine providers in Virginia.

See all hospice and palliative medicine providers in Virginia

Medicare billing

Part B allowed, 2024
$51,191
Medicare patients
156
Services billed
352

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OxycontinOxycodone Hcl14$8,648
Fentanyl69$5,447
Oxycodone Hcl169$3,910
Duloxetine Hcl35$1,854
Morphine Sulfate ErMorphine Sulfate51$1,425
Dexamethasone58$1,238
Gabapentin64$1,027
Celecoxib22$994
Morphine Sulfate16$429
Hydromorphone Hcl22$247
Escitalopram Oxalate13$170
Tramadol Hcl28$164
Lorazepam30$106
Metoclopramide Hcl13$94
Citalopram HbrCitalopram Hydrobromide21$50

Paid to pharmacies, not to this prescriber.

Other hospice and palliative medicine in Fairfax

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →